Insider trades
Stephane Bancel, Director of Generate Biomedicines GENB, has filed 2 purchases and 218 sales on the open market. The latest trade was on 03/02.
Stephane Bancel
Director
Photo credit- Company
- Generate Biomedicines GENB
- First filing
- 23/01/06
- Trades
- 338 trades
- Buys / sales
- 2 / 218
- 12-month net buying
- No record
- Last trade
- 03/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MRNA | Open-market buy | 25/03/03 | 25/03/04 | 160,314 sh2 trades | $31.22avg. | $5,004,318.13 | +1.8% |
ModernaMRNA | Open-market sale10b5-1 plan | 24/02/16 | 24/02/16 | 26,351 sh | $88.88 | $2,342,076.88 | −0.5% |
MRNA | Open-market sale10b5-1 plan | 23/06/28 | 23/06/30 | 27,155 sh4 trades | $121.63avg. | $3,302,907.46 | −0.5% |
MRNA | Open-market sale10b5-1 plan | 23/06/21–23/06/22 | 23/06/23 | 80,000 sh4 trades | $120.70avg. | $9,655,713.7 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/06/14–23/06/15 | 23/06/16 | 80,000 sh8 trades | $127.27avg. | $10,181,873.85 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/06/07–23/06/08 | 23/06/09 | 80,000 sh5 trades | $124.91avg. | $9,992,784 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/05/31–23/06/01 | 23/06/02 | 80,000 sh7 trades | $127.44avg. | $10,195,031.09 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/05/24–23/05/25 | 23/05/26 | 80,000 sh7 trades | $129.40avg. | $10,351,633.13 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/05/17–23/05/18 | 23/05/19 | 80,000 sh8 trades | $124.55avg. | $9,963,647.07 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/05/10–23/05/11 | 23/05/12 | 80,000 sh7 trades | $129.43avg. | $10,354,518.68 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/05/03–23/05/04 | 23/05/05 | 80,000 sh9 trades | $133.50avg. | $10,679,623.11 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/04/26–23/04/27 | 23/04/28 | 80,000 sh7 trades | $131.17avg. | $10,493,709.9 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/04/19–23/04/20 | 23/04/21 | 80,000 sh7 trades | $142.94avg. | $11,434,801.51 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/04/12–23/04/13 | 23/04/14 | 80,000 sh7 trades | $158.72avg. | $12,697,675.3 | −1.5% |
MRNA | Open-market sale10b5-1 plan | 23/04/05–23/04/06 | 23/04/07 | 80,000 sh10 trades | $156.06avg. | $12,484,535.37 | −1.5% |
MRNA | Open-market sale | 23/03/29–23/03/30 | 23/03/31 | 80,000 sh7 trades | $148.49avg. | $11,879,129.76 | −1.5% |
MRNA | Open-market sale | 23/03/22–23/03/23 | 23/03/24 | 80,000 sh10 trades | $149.72avg. | $11,977,487.8 | −1.5% |
MRNA | Open-market sale | 23/03/15–23/03/16 | 23/03/17 | 80,000 sh9 trades | $149.84avg. | $11,987,223.51 | −1.5% |
MRNA | Open-market sale | 23/03/08–23/03/09 | 23/03/10 | 80,000 sh8 trades | $140.29avg. | $11,223,168.11 | −1.5% |
MRNA | Open-market sale | 23/03/01–23/03/02 | 23/03/03 | 80,000 sh8 trades | $136.34avg. | $10,907,156.8 | −1.5% |
